Assessment of immune responses of the flagellin (FliC) fused to FimH adhesin of Uropathogenic Escherichia coli

Molecular Immunology

Volumn 54, Issue 1, 2013, Pages 32-39

  Karam, Mohammad Reza Asadi ^a   Oloomi, Mana ^a   Mahdavi, Mehdi ^a   Habibi, Mehri ^a   Bouzari, Saeid ^a  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

FimH; FliC; Fusion; Montanide; UPEC; UTI

Indexed keywords

ADHESIN; BACTERIAL ANTIGEN; FLAGELLIN; HYBRID PROTEIN; IMMUNOGLOBULIN G1; MONTANIDE ISA 51; PROTEIN FIMH; PROTEIN FLIC; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; CELLULAR IMMUNITY; CONTROLLED STUDY; CYSTITIS; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; KIDNEY INFECTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TH1 CELL; TH2 CELL; UROPATHOGENIC ESCHERICHIA COLI;

ADHESINS, ESCHERICHIA COLI; ANIMALS; ANTIBODY FORMATION; CELLS, CULTURED; CYTOKINES; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FIMBRIAE PROTEINS; FLAGELLIN; IMMUNITY, HUMORAL; MICE; MICE, INBRED BALB C; RECOMBINANT FUSION PROTEINS; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI;

ESCHERICHIA COLI; MUS;

EID: 84870307300     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2012.11.002     Document Type: Article

References (37)

1. Anderson G.G., Martin S.M., Hultgren S.J. Host subversion by formation of intracellular bacterial communities in the urinary tract. Microbes and Infection 2004, 6:1094-1101.
2. Asadi K.M., Oloomi M., Habibi M., Bouzari S. Cloning of fimH and fliC and expression of the fusion protein FimH/FliC from Uropathogenic Escherichia coli (UPEC) isolated in Iran. Iranian Journal of Microbiology 2012, 4:55-62.
3. Bargieri D.Y., Rosa D.S., Braga C.J., Carvalho B.O., Costa F.T., Espindola N.M., Vaz A.J., Soares I.S., Ferreira L.C., Rodrigues M.M. New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin. Vaccine 2008, 26:6132-6142.
4. Bien J., Sokolova O., Bozko P. Role of uropathogenic Escherichia coli virulence factors in development of urinary tract infection and kidney damage. International Journal of Nephrology 2012, 2012:681473.
5. Billips B.K., Yaggie R.E., Cashy J.P., Schaeffer A.J., Klumpp D.J. A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli. Journal of Infectious Diseases 2009, 200:263-272.
6. Cox S.J., Aggarwal N., Statham R.J., Barnett P.V. Longevity of antibody and cytokine responses following vaccination with high potency emergency FMD vaccines. Vaccine 2003, 21:1336-1347.
7. Cuadros C., Lopez-Hernandez F.J., Dominguez A.L., McClelland M., Lustgarten J. Flagellin fusion proteins as adjuvants or vaccines induce specific immune responses. Infection and Immunity 2004, 72:2810-2816.
8. Dhakal B.K., Kulesus R.R., Mulvey M.A. Mechanisms and consequences of bladder cell invasion by uropathogenic Escherichia coli. European Journal of Clinical Investigation 2008, 38(Suppl. 2):2-11.
9. Goluszko P., Goluszko E., Nowicki B., Nowicki S., Popov V., Wang H.Q. Vaccination with purified Dr Fimbriae reduces mortality associated with chronic urinary tract infection due to Escherichia coli bearing Dr adhesin. Infection and Immunity 2005, 73:627-631.
10. Habjanec L., Halassy B., Tomasic J. Immunomodulatory activity of novel adjuvant formulations based on Montanide ISA oil-based adjuvants and peptidoglycan monomer. International Immunopharmacology 2008, 8:717-724.
11. Hagan E.C., Mobley H.L. Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection. Infection and Immunity 2007, 75:3941-3949.
12. Halassy B., Vdovic V., Habjanec L., Balija M.L., Gebauer B., Sabioncello A., Santek T., Tomasic J. Effectiveness of novel PGM-containing incomplete Seppic adjuvants in rabbits. Vaccine 2007, 25:3475-3481.
13. Honko A.N., Mizel S.B. Effects of flagellin on innate and adaptive immunity. Immunologic Research 2005, 33:83-101.
14. Jones-Carson J., Balish E., Uehling D.T. Susceptibility of immunodeficient gene-knockout mice to urinary tract infection. Journal of Urology 1999, 161:338-341.
15. Lane M.C., Alteri C.J., Smith S.N., Mobley H.L. Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:16669-16674.
16. Lane M.C., Lockatell V., Monterosso G., Lamphier D., Weinert J., Hebel J.R., Johnson D.E., Mobley H.L. Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract. Infection and Immunity 2005, 73:7644-7656.
17. Lane M.C., Simms A.N., Mobley H.L. complex interplay between type 1 fimbrial expression and flagellum-mediated motility of uropathogenic Escherichia coli. Journal of Bacteriology 2007, 189:5523-5533.
18. Langermann S., Ballou W.R. Vaccination utilizing the FimCH complex as a strategy to prevent Escherichia coli urinary tract infections. Journal of Infectious Diseases 2001, 183(Suppl. 1):S84L 6.
19. Langermann S., Mollby R., Burlein J.E., Palaszynski S.R., Auguste C.G., DeFusco A., Strouse R., Schenerman M.A., Hultgren S.J., Pinkner J.S., Winberg J., Guldevall L., Soderhall M., Ishikawa K., Normark S., Koenig S. Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli. Journal of Infectious Diseases 2000, 181:774-778.
20. Martinez J.J., Mulvey M.A., Schilling J.D., Pinkner J.S., Hultgren S.J. Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. EMBO Journal 2000, 19:2803-2812.
21. McSorley S.J., Ehst B.D., Yu Y., Gewirtz A.T. Bacterial flagellin is an effective adjuvant for CD4+ T cells in vivo. Journal of Immunology 2002, 169:3914-3919.
22. Nesta B., Spraggon G., Alteri C., Moriel D.G., Rosini R., Veggi D., Smith S., Bertoldi I., Pastorello I., Ferlenghi I., Fontana M.R., Frankel G., Mobley H.L., Rappuoli R., Pizza M., Serino L., Soriani M. FdeC, a novel broadly conserved Escherichia coli adhesin eliciting protection against urinary tract infections. MBio 2012, 3.
23. Nielubowicz G.R., Mobley H.L. Host-pathogen interactions in urinary tract infection. Nature Reviews Urology 2010, 7:430-441.
24. O'Hanley P., Lalonde G., Ji G. Alpha-hemolysin contributes to the pathogenicity of piliated digalactoside-binding Escherichia coli in the kidney: efficacy of an alpha-hemolysin vaccine in preventing renal injury in the BALB/c mouse model of pyelonephritis. Infection and Immunity 1991, 59:1153-1161.
25. Ragnarsdottir B., Fischer H., Godaly G., Gronberg-Hernandez J., Gustafsson M., Karpman D., Lundstedt A.C., Lutay N., Ramisch S., Svensson M.L., Wullt B., Yadav M., Svanborg C. TLR- and CXCR1-dependent innate immunity: insights into the genetics of urinary tract infections. European Journal of Clinical Investigation 2008, 38(Suppl. 2):12-20.
26. Reichelt P., Schwarz C., Donzeau M. Single step protocol to purify recombinant proteins with low endotoxin contents. Protein Expression and Purification 2006, 46:483-488.
27. Roberts J.A., Kaack M.B., Baskin G., Chapman M.R., Hunstad D.A., Pinkner J.S., Hultgren S.J. Antibody responses and protection from pyelonephritis following vaccination with purified Escherichia coli PapDG protein. Journal of Urology 2004, 171:1682-1685.
28. Russo T.A., McFadden C.D., Carlino-MacDonald U.B., Beanan J.M., Olson R., Wilding G.E. The Siderophore receptor IroN of extraintestinal pathogenic Escherichia coli is a potential vaccine candidate. Infection and Immunity 2003, 71:7164-7169.
29. Schwan W.R. Flagella allow uropathogenic Escherichia coli ascension into murine kidneys. International Journal of Medical Microbiology 2008, 298:441-447.
30. Smith K.D., Andersen-Nissen E., Hayashi F., Strobe K., Bergman M.A., Barrett S.L., Cookson B.T., Aderem A. Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nature Immunology 2003, 4:1247-1253.
31. Song J., Abraham S.N. Innate and adaptive immune responses in the urinary tract. European Journal of Clinical Investigation 2008, 38(Suppl. 2):21-28.
32. Thumbikat P., Berry R.E., Zhou G., Billips B.K., Yaggie R.E., Zaichuk T., Sun T.T., Schaeffer A.J., Klumpp D.J. Bacteria-induced uroplakin signaling mediates bladder response to infection. PLoS Pathogens 2009, 5:e1000415.
33. Vicente-Suarez I., Takahashi Y., Cheng F., Horna P., Wang H.W., Wang H.G., Sotomayor E.M. Identification of a novel negative role of flagellin in regulating IL-10 production. European Journal of Immunology 2007, 37:3164-3175.
34. Walters M.S., Mobley H.L. Identification of uropathogenic Escherichia coli surface proteins by shotgun proteomics. Journal of Microbiological Methods 2009, 78:131-135.
35. Wieser A., Romann E., Magistro G., Hoffmann C., Norenberg D., Weinert K., Schubert S. A multiepitope subunit vaccine conveys protection against extraintestinal pathogenic Escherichia coli in mice. Infection and Immunity 2010, 78:3432-3442.
36. Wiles T.J., Kulesus R.R., Mulvey M.A. Origins and virulence mechanisms of uropathogenic Escherichia coli. Experimental and Molecular Pathology 2008, 85:11-19.
37. Wright K.J., Seed P.C., Hultgren S.J. Uropathogenic Escherichia coli flagella aid in efficient urinary tract colonization. Infection and Immunity 2005, 73:7657-7668.